FBRX
Forte Biosciences
$76.50
+$21.72 (+39.65%)Jul 27, 2026
Key metrics
The numbers that frame FBRX today
- Market cap
- $1.57B
- P/E (TTM)
- -20.7
- EV / FCF
- -25.4
- ROIC
- 641.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $9.22
- 52wk High
- $76.60
Growth
Revenue and earnings trend for FBRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about FBRX
Is Forte Biosciences a good buy?
No. Forte Biosciences has strong momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Forte Biosciences is selling at a high price.
What is the market capitalization of FBRX?
Forte Biosciences's market capitalization is $1.57B.
What is the P/E ratio for FBRX stock?
Forte Biosciences's current P/E ratio is -20.7.
What is the 52-week high for FBRX stock?
The 52-week high for Forte Biosciences is $76.60. The current close of $76.50 is 0.1% below that high.
What is the 52-week low for FBRX stock?
The 52-week low for Forte Biosciences is $9.22. The current close of $76.50 is 729.7% above that low.
Does FBRX stock pay dividends?
Forte Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for FBRX?
Forte Biosciences's Debt / Equity ratio is 0.